CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease

CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease

Abstract Diagnosis of dementia with Lewy bodies (DLB) is challenging and specific biofluid biomarkers are highly needed. We employed proximity extension-based assays to measure 665 proteins in the cerebrospinal fluid (CSF) from patients with DLB (n = 109), Alzheimer´s disease (AD, n = 235) and cogni...

Full description

Bibliographic Details
Main Authors:	Marta del Campo, Lisa Vermunt, Carel F. W. Peeters, Anne Sieben, Yanaika S. Hok-A-Hin, Alberto Lleó, Daniel Alcolea, Mirrelijn van Nee, Sebastiaan Engelborghs, Juliette L. van Alphen, Sanaz Arezoumandan, Alice Chen-Plotkin, David J. Irwin, Wiesje M. van der Flier, Afina W. Lemstra, Charlotte E. Teunissen
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-09-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-023-41122-y

Similar Items

Thimet oligopeptidase as a potential CSF biomarker for Alzheimer's disease: A cross‐platform validation study
by: Yanaika S. Hok‐A‐Hin, et al.
Published: (2023-07-01)

Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer’s disease
by: Yanaika S. Hok-A-Hin, et al.
Published: (2023-05-01)

Discovery of novel CSF biomarkers to predict progression in dementia using machine learning
by: Dea Gogishvili, et al.
Published: (2023-04-01)

Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF
by: Walter A. Boiten, et al.
Published: (2020-12-01)

Comparing CSF amyloid‐beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET status
by: Eline A. J. Willemse, et al.
Published: (2021-01-01)

Contactin-1 Is Reduced in Cerebrospinal Fluid of Parkinson’s Disease Patients and Is Present within Lewy Bodies
by: Madhurima Chatterjee, et al.
Published: (2020-08-01)

Correction: Boiten et al. Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF. <i>Cells</i> 2021, <i>10</i>, 38
by: Walter A. Boiten, et al.
Published: (2022-02-01)

White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation
by: Teunissen, C, et al.
Published: (2018)

Determinants of informal care time, distress, depression, and quality of life in care partners along the trajectory of Alzheimer's disease
by: Arenda Mank, et al.
Published: (2023-04-01)

Age‐ and disease‐specific reference values for neurofilament light presented in an online interactive support interface
by: Lisa Vermunt, et al.
Published: (2022-11-01)

CSF Proteomic Alzheimer’s Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals
by: Betty Marije Tijms, et al.
Published: (2021-08-01)

ecpc: an R-package for generic co-data models for high-dimensional prediction
by: Mirrelijn M. van Nee, et al.
Published: (2023-04-01)

Experiences with and perspectives on advance care planning in young- and late- onset dementia: A focus group study with physicians from various disciplines
by: Romy Van Rickstal, et al.
Published: (2023-03-01)

Plasma protein biomarkers for the prediction of CSF amyloid and tau and [18F]-flutemetamol PET scan result
by: Westwood, S, et al.
Published: (2018)

Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning
by: Alexander Neumann, et al.
Published: (2023-10-01)

Arylesterase Activity of Paraoxonase-1 in Serum and Cerebrospinal Fluid of Patients with Alzheimer’s Disease and Vascular Dementia
by: Arianna Romani, et al.
Published: (2020-05-01)

CSF biomarker analysis of ABCA7 mutation carriers suggests altered APP processing and reduced inflammatory response
by: Lena Duchateau, et al.
Published: (2023-11-01)

CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease
by: Delvenne, A, et al.
Published: (2024)

Vroegdiagnostiek van de ziekte van Alzheimer: de rol van Positron Emissie Tomografie (PET)
by: Wiesje M. van der Flier, et al.
Published: (2013-08-01)

CSF Biomarkers Reflecting Protein Pathology and Axonal Degeneration Are Associated with Memory, Attentional, and Executive Functioning in Early-Stage Parkinson′s Disease
by: Linda P. Oosterveld, et al.
Published: (2020-11-01)

CSF proteomic signature predicts progression to Alzheimer's disease dementia
by: Eleonora M. Vromen, et al.
Published: (2022-01-01)

Mediatieve therapie in de thuiszorg: Onbekend en onbenut
by: R. J. G. M. Geelen, et al.
Published: (2014-01-01)

Gestandaardiseerd meten van persoonlijkheidstoornissen bij ouderen
by: Gina M.P. Rossi, et al.
Published: (2020-05-01)

Plasma Markers of Alzheimer's Disease Pathology, Neuronal Injury, and Astrocytic Activation and MRI Load of Vascular Pathology and Neurodegeneration: The SMART‐MR Study
by: Emma L. Twait, et al.
Published: (2024-02-01)

rags2ridges: A One-Stop-ℓ2-Shop for Graphical Modeling of High-Dimensional Precision Matrices
by: Carel F. W. Peeters, et al.
Published: (2022-05-01)

Persoonlijkheidsstoornissen bij ouderen: diagnostische aspecten
by: spj van alphen
Published: (2024-02-01)

J.P. Sigmond, Zeemacht in Holland en Zeeland in de zestiende eeuw
by: Marc van Alphen
Published: (2014-07-01)

Exoticism or the Translation of Cultural Difference = Exotismo o la traducción de la diferencia cultural
by: Ernst van Alphen
Published: (2016-06-01)

J.P. Sigmond, Zeemacht in Holland en Zeeland in de zestiende eeuw
by: Marc van Alphen
Published: (2014-07-01)

Integratie van de DSM-5 en ICD-11 Maladaptieve Trekken bij Ouderen: Constructvaliditeit van de PID-5-BF+M
by: Morag F. Facon, et al.
Published: (2023-04-01)

Subarachnoid CSF hyperintensities at 7 tesla FLAIR MRI: A novel marker in cerebral amyloid angiopathy
by: Emma A. Koemans, et al.
Published: (2023-01-01)

S-nitrosylation of CSF1 receptor increases the efficacy of CSF1R blockage against prostate cancer
by: Fakiha Firdaus, et al.
Published: (2022-10-01)

Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration
by: Joery Goossens, et al.
Published: (2018-03-01)

CNS barriers and modern CSF diagnostics /
by: Felgenhauer, Klaus, et al.
Published: (1993)

Mediatietherapie bij ouderen met een persoonlijkheidsstoornis: Een verpleegkundige benadering
by: Johannes W. S. A. Osterloh, et al.
Published: (2018-07-01)

Cerebrospinal fluid inflammatory biomarkers for disease progression in Alzheimer’s disease and multiple sclerosis: a systematic review
by: Joke Temmerman, et al.
Published: (2023-07-01)

Microglial Homeostasis Requires Balanced CSF-1/CSF-2 Receptor Signaling
by: Violeta Chitu, et al.
Published: (2020-03-01)

Immune Evasion of G-CSF and GM-CSF in Lung Cancer
by: Yeonhee Park, et al.
Published: (2024-01-01)

Variability of CSF Alzheimer's disease biomarkers: implications for clinical practice.
by: Stephanie J B Vos, et al.
Published: (2014-01-01)

A longitudinal study on quality of life along the spectrum of Alzheimer’s disease
by: Arenda Mank, et al.
Published: (2022-09-01)